Fig. 2From: Systems pharmacology based approach to investigate the in-vivo therapeutic efficacy of Albizia lebbeck (L.) in experimental model of Parkinson’s diseaseHang time latency in experimental groups; values are expressed as mean ± SEM, n = 6. The intergroup variation was measure by Prism one-way ANOVA followed by tukey’s multiple comparison post-hoc test. ***P 0.001 vs HPD group, ###P < 0.001 vs NC (Normal control)Back to article page